Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1996 2
2000 1
2002 2
2003 4
2004 9
2005 18
2006 9
2007 10
2008 11
2009 13
2010 13
2011 7
2012 10
2013 8
2014 5
2015 4
2016 5
2017 5
2018 3
2019 1
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 11752030

127 results
Results by year
Filters applied: . Clear all
Page 1
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Zoccali C, et al. J Am Soc Nephrol. 2002 Jan;13(1):134-41. J Am Soc Nephrol. 2002. PMID: 11752030 Free article.
Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E, Waked E, Nabil M, El-Bendary O. Abdallah E, et al. Kidney Blood Press Res. 2012;35(4):247-53. doi: 10.1159/000334649. Epub 2012 Jan 26. Kidney Blood Press Res. 2012. PMID: 22286012 Free article.
Adiponectin in essential hypertension.
Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Mallamaci F, et al. J Nephrol. 2002 Sep-Oct;15(5):507-11. J Nephrol. 2002. PMID: 12455716
Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients.
El-Shafey EM, Shalan M. El-Shafey EM, et al. Ther Apher Dial. 2014 Apr;18(2):185-92. doi: 10.1111/1744-9987.12065. Epub 2013 Jul 3. Ther Apher Dial. 2014. PMID: 24720410
Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease.
Zoccali C, Mallamaci F, Tripepi G. Zoccali C, et al. Nephrol Dial Transplant. 2004 Aug;19 Suppl 5:V67-72. doi: 10.1093/ndt/gfh1059. Nephrol Dial Transplant. 2004. PMID: 15284363 Review.
Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
Díez JJ, Iglesias P, Fernández-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R. Díez JJ, et al. Clin Endocrinol (Oxf). 2005 Feb;62(2):242-9. doi: 10.1111/j.1365-2265.2005.02207.x. Clin Endocrinol (Oxf). 2005. PMID: 15670203
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D; MMKD Study Group. Becker B, et al. J Am Soc Nephrol. 2005 Apr;16(4):1091-8. doi: 10.1681/ASN.2004090742. Epub 2005 Mar 2. J Am Soc Nephrol. 2005. PMID: 15743998 Free article.
Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D. Guebre-Egziabher F, et al. Nephrol Dial Transplant. 2005 Jan;20(1):129-34. doi: 10.1093/ndt/gfh568. Epub 2004 Dec 7. Nephrol Dial Transplant. 2005. PMID: 15585515
Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
Amira OC, Naicker S, Manga P, Sliwa K, Mia A, Raal F, Crowther NJ, Immelman RA, Olorunju S. Amira OC, et al. Hemodial Int. 2012 Jan;16(1):59-68. doi: 10.1111/j.1542-4758.2011.00622.x. Hemodial Int. 2012. PMID: 22099423
Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT, Hsu YJ, Chu NF, Lai CH, Chiu JS, Lin SH. Tsao YT, et al. J Nephrol. 2008 Sep-Oct;21(5):744-52. J Nephrol. 2008. PMID: 18949730
127 results
Jump to page
Feedback